Cts Corporation · NYSE:CTS

Cts — Q3 2023 Earnings Presentation

17 slides from Cts's earnings presentation, Oct 26, 2023

  1. Slide 1: CTS Corporation 3rd Quarter 2023 Earnings Call

    CTS Corporation 3rd Quarter 2023 Earnings Call October 26, 2023

  2. Slide 2: Forward-Looking Statements

    Forward-Looking Statements This document contains statements that are, or may be deemed to be, forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, any financial or other guidance, sta

  3. Slide 3: Advancing Strategic Priorities While Navigating Operating Challenges

    Advancing Strategic Priorities While Navigating Operating Challenges 7 new non-Transportation customers Won first motor position development award 11 new EV platform wins $134.6M Revenue -11% YoY 34.5% Adjusted Gross Margin1 (210) bps YoY $0.54 Adj. Earnings Per Share1 $(0.08) YoY Q3 2023 Financials

  4. Slide 4: Diversifying into Attractive Non-transportation End Markets

    Diversifying into Attractive Non-transportation End Markets Industrial Aerospace & Defense Medical Revenue ($ Millions) Revenue ($ Millions) Revenue ($ Millions) Near-Term Softness as Customer Inventories Stabilize; Tailwinds from Megatrends Support Long-Term Strategy Key New Wins HVAC Tunable Lense

  5. Slide 5: Continued Progress in Transportation – Won Motor Position Sensing Development Award

    Continued Progress in Transportation – Won Motor Position Sensing Development Award ($ Millions) Revenue Total Booked Business1 ($ Billions) Chassis Height Sensor Accelerator Modules Brake Position Sensor Belt Tension Sensor Seat Track Position Sensor Seat Belt Buckle Switch Sensor 95% of existing l

  6. Slide 6: FY 2023 Guidance

    $2.25 $2.15 Notes: 1 CAGR based on mid-point of 2023 guidance 2 Adjusted Diluted EPS is a non-GAAP financial measure. Refer to Appendix for reconciliation of non-GAAP financial measures to the most directly comparable financial measures calculated and presented in accordance with GAAP. FY 2023 Guida

  7. Slide 7: 3rd Quarter Financial Results

    3rd Quarter Financial Results

  8. Slide 8: Q3 2023 Financial Results

    Notes: All comparisons vs. same period in prior year unless otherwise noted. 1 Adj. Diluted EPS, Adj. Gross Margin and Adj. EBITDA Margin are non-GAAP financial measures. Refer to Appendix for reconciliation of non-GAAP financial measures to the most directly comparable financial measures calculated

  9. Slide 9: Strong Balance Sheet Solid Foundation for Strategic M&A

    Cash and Debt2 $30M Returned to Shareholders YTD Q3 20234 $46M YTD Q3 2023 Free Cash Flow3 Strong Balance Sheet Solid Foundation for Strategic M&A $11M YTD Q3 2023 Capital Expenditures Borrowed Total Facility Operating Cash Flow1 Prioritizing strong cash flow generation ($ Millions) ($ Millions) Not

  10. Slide 10: Q&A

    Q&A cts

  11. Slide 11: Appendix

    Appendix cts

  12. Slide 12: Non-GAAP Financial Measures

    Non-GAAP Financial Measures From time to time, CTS may use non-GAAP financial measures in discussing CTS’ business. These measures are intended to supplement, not replace, CTS’ presentation of its financial results in accordance with U.S. GAAP. CTS believes that the non-GAAP financial measures prese

  13. Slide 13: Adjusted Diluted EPS Regulation G Schedules

    Adjusted Diluted EPS Regulation G Schedules 2023 2022 2023 2022 2022 2021 2020 Diluted earnings (loss) per share 0.44 $ 0.37 $ 1.43 $ 1.38 $ 1.85 $ (1.30) $ $1.06 Restructuring charges 0.10 0.01 0.17 0.04 0.05 0.06 0.04 Foreign currency (gain) loss (0.01) 0.01 0.07 0.12 0.15 0.10 (0.16) Non-cash pen

  14. Slide 14: Regulation G Schedules: Adjusted EBITDA Margin

    Regulation G Schedules ($ Millions) Adjusted EBITDA Margin 2023 2022 2023 2022 2022 2021 2020 Net earnings (loss) 14.0 $ 11.8 $ 45.2 $ 44.6 $ 59.6 $ (41.9) $ 34.7 $ Net sales 134.6 $ 151.9 $ 425.7 $ 444.6 $ 586.9 $ 512.9 $ 424.1 $ Net earnings (loss) margin 10.4% 7.8% 10.6% 10.0% 10.2% -8.2% 8.2% De

  15. Slide 15: Regulation G Schedules: Adjusted Gross Margin

    Regulation G Schedules ($ Millions) Adjusted Gross Margin 2023 2022 2023 2022 2022 2021 2020 Gross margin 46.4 $ 53.3 $ 148.8 $ 159.5 $ 210.5 $ 184.6 $ 139.1 $ Net sales 134.6 $ 151.9 $ 425.7 $ 444.6 $ 586.9 $ 512.9 $ 424.1 $ Gross margin as a % of net sales 34.5% 35.1% 35.0% 35.9% 35.9% 36.0% 32.8%

  16. Slide 16: Regulation G Schedules: Adjusted Net Earnings

    Regulation G Schedules ($ Millions) Adjusted Net Earnings 2023 2022 2023 2022 2022 2021 2020 Net earnings (loss) (A) 14.0 $ 11.8 $ 45.2 $ 44.6 $ 59.6 $ (41.9) $ 34.7 $ Net sales 134.6 $ 151.9 $ 425.7 $ 444.6 $ 586.9 $ 512.9 $ 424.1 $ Net earnings (loss) as a % of net sales 10.4% 7.8% 10.6% 10.0% 10.

  17. Slide 17: Free Cash Flow and Controllable Working Capital Regulation G Schedules

    ($ Millions) Free Cash Flow Regulation G Schedules ($ Millions) Controllable Working Capital 2023 2022 2023 2022 2022 2021 2020 Net cash provided by operating activities 22.1 $ 60.4 $ 56.7 $ 60.1 $ 121.2 $ 86.1 $ 76.8 $ Capital expenditures (2.7) (2.3) (11.2) (8.1) (14.3) (15.6) (14.9) Free cash flo

CTS — Q3 2023 Earnings Presentation on 6ix